Divis Laboratories explosion: One dead and another sustains serious burns Ruby Khatun Khatun22 May 2017 5:42 PM ISTVisakhapatnam: In an explosion at the dumping yard of the Divis Laboratories, one worker died and another sustained serious burns while segregating...
Higher rate of heart problems seen with Amgen bone drug in trial Ruby Khatun Khatun22 May 2017 12:17 PM ISTAmgen Inc and UCB SA said on Sunday they did not expect their experimental osteoporosis drug to win U.S. approval this year after a higher rate of...
Natco Pharma gets green nod for Rs 480 crore expansion project Ruby Khatun Khatun22 May 2017 12:03 PM ISTNew Delhi: Natco Pharma has received environment clearance (EC) for its Rs 480 crore expansion project in Telangana that would generate 1,500 jobs.The...
India to unveil new drug policy: Officials Ruby Khatun Khatun22 May 2017 9:17 AM ISTWASHINGTON: India is expected to roll out a new drug policy and devise rules for clinical trials that may bring new projects to the country, a top...
Abbott India Q4 net dips 29 per cent to Rs 42 crore Ruby Khatun Khatun21 May 2017 10:40 AM ISTNew Delhi: Pharma firm Abbott India on Friday reported a 28.69 per cent plunge in standalone net profit to Rs 42.06 crore for the fourth quarter ended...
Pfizer drug from Medivation deal shows promise in breast cancer: study Ruby Khatun Khatun21 May 2017 9:42 AM ISTA breast cancer drug that Pfizer Inc acquired with its $14 billion purchase of Medivation showed promising anti-tumor activity following prior...
Janssen files suit in U.S. to block sale of Samsung Bioepis' Remicade copy Ruby Khatun Khatun21 May 2017 9:40 AM ISTSEOUL: A unit of healthcare conglomerate Johnson & Johnson filed a lawsuit to block a copy of its rheumatoid arthritis drug Remicade made by South...
CHMP backs Novartis's Zykadia for first-line use in lung cancer Ruby Khatun Khatun21 May 2017 9:39 AM ISTNovartis's push to win approval for Zykadia as an initial treatment for a type of lung cancer got a lift on Friday with a positive recommendation from...
India's drug pricing regulator clamps down on drug cocktails Ruby Khatun Khatun20 May 2017 2:30 PM ISTMumbai: India's drug pricing regulator has demanded explanations from 65 domestic and global drugmakers for selling new forms of essential diabetes...
USFDA Grants Bayer Priority Review for Investigational Compound Copanlisib in Follicular Lymphoma Ruby Khatun Khatun20 May 2017 10:35 AM ISTWHIPPANY, N.J: Bayer announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review designation for the New Drug Application...
hCue relaunches itself with new platform myhCue Ruby Khatun Khatun20 May 2017 10:35 AM ISTChennai : hCue, the most sought-after healthcare platform for doctors and pharmacies just got bigger with its new domain myhCue.com. hCue's...
GE Healthcare’s FlexFactory to power Dr Reddy’s biosimilar expansion plans Ruby Khatun Khatun20 May 2017 10:34 AM ISTGE Healthcare announced that Dr. Reddy’s Laboratories Limited will install India’s first-ever FlexFactory, a single-use manufacturing platform to...
